Future investigations should lead to a better understanding of whether disrupting Ca2+ entry at KV2–CaV1 nanodomains has beneficial effects on disease progression in NPC disease models, as it does for stroke models66,99. This evidence concerns the gene CAV1 and nasopharyngeal carcinoma.